erectile%20dysfunction
ERECTILE DYSFUNCTION

Erectile dysfunction is the inability to attain and maintain an erection enough to have satisfactory sexual performance for ≥3 months.

It is when the patient complains of partial erection that could not attain vaginal penetration.

Complete loss of penile rigidity is uncommon.

Initial penile erections can penetrate but early detumescence occurs without ejaculation.

Erectile%20dysfunction Management

Prevention

Treat Psychosocial Factors

  • Confronting depression or substance abuse
  • Sexual education/correction of misinformation

Discontinue Offending Medications

  • Many common medications may affect male sexual function
    • Eg antidepressants, antipsychotics, anti-arrhythmics, many antihypertensives, anti-androgens & steroids

Counselling

Sexual Counseling & Education

  • Encompass sex therapy, psychosocial therapy & marital therapy
  • May be appropriate for patient &/or partner
  • May be used to address & correct relationship issues, stress factors (eg work, finances, family, etc)
  • Decreased sexual drive may be due to psychologic issues & individual may benefit from sexual therapy
  • Use as adjunct to other erectile dysfunction therapy to address patient’s psychological reaction to their need for erectile dysfunction treatment
  • Sexual counseling & education may be preferred by patients/partners because it is noninvasive & has broad applicability

Follow Up

  • Patients receiving phosphodiesterase inhibitors must have regular follow-up of efficacy, side effects & any relevant change in their health status (especially cardiovascular health) including medications
  • Failure to respond to phosphodiesterase inhibitor may be due to: 
    • Hormonal abnormalities
    • Drug interactions
    • Food interference w/ absorption
    • Timing & frequency of dosing
    • Lack of adequate sexual stimulation
    • Heavy alcohol use
    • Patient’s relationship w/ his partner
  • A patient who fails initial trial of phosphodiesterase inhibitor (after above factors are modified) may be given a different phosphodiesterase inhibitor or proceed w/ other more invasive therapies for erectile dysfunction
Editor's Recommendations
Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 5 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.